“Life sciences” is a common name of a raft of sciences dealing with living organisms and various types of life processes. The life sciences industry can be divided into several sub-groups such as Biotech & Pharma, healthcare, medical devices, research and lab services. Pharmaceuticals form the largest market sector; its sales are predicted to override USD 1 trillion by 2015.
The life sciences market proved to be rather resistant to unfavorable economic conditions. It has experienced healthy growth over the recent years on the back of the population increase, ongoing technological advancements and rising awareness of healthcare. Drug discovery, medical equipment and regenerative medicine represent the most promising market sectors.
A wealthy collection of the research reports providing extensive overview of the life sciences market is at hand in this MarketPublishers’ catalogue. Current situation and historic development of the market are reviewed in the researches. The reports thoroughly examine market segments, disclose essential information on the market size and characterize the industry dynamics and identify major forces shaping the market. Moreover, the long-term and short-term future outlooks for the market can be found in the research reports.
Publications found:
253,194
Sort by:
2017 Latvia Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Lithuania Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Malta Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Netherlands Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Norway Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Poland Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Portugal Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Romania Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Slovakia Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Slovenia Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Sweden Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Switzerland Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Australia Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Austria Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Belgium Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Bulgaria Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Canada Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Cyprus Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Czech Republic Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support ... over 30 NAT assays. Product/Technology Review Comparison of leading molecular diagnosticanalyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation ...
March 2017
1120 pages
2017 Denmark Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Estonia Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Finland Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Greece Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Hungary Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Iceland Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Ireland Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Latvia Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Lithuania Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Malta Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Netherlands Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Norway Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Poland Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Portugal Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Romania Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Slovakia Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Slovenia Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Sweden Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Switzerland Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...
March 2017
535 pages
